Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A

Five patients with hemophilia A had dramatic reductions in bleeding episodes after undergoing autologous HSCT with lentiviral vector–transduced cells encoding a CD68-targeted factor VIII transgene.

​   The New England Journal of Medicine: Search Results in Hematology/Oncology